sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 13, 2026

Zacks Industry Outlook Highlights Verizon, AT&T and Liberty Latin America

View original at finance.yahoo.com
“On the basis of the trailing 12-month enterprise value-to-EBITDA (EV/EBITDA), which is the most appropriate multiple for valuing telecom stocks, the industry is currently trading at 9.03X compared with the S&P 500”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Over the past five years, the wireless industry has traded as high as 9.42X EV/EBITDA, as low as 6.33X and at the median of 7.51X

    80% confidence
  • The Zacks Wireless National industry appears to be plagued by high capital expenditures for infrastructure upgrades, tariff uncertainty, supply-chain disruptions due to the prolonged Russia-Ukraine war, Middle East tensions and high customer inventory levels

    80% confidence
  • Verizon appears to be at a critical inflection point and remains focused on making necessary capital expenditures

    80% confidence
  • Verizon, AT&T, and Liberty Latin America are likely to gain from higher demand for scalable infrastructure for sustainable networks with a wide proliferation of IoT, wireless traction and solid broadband momentum

    80% confidence
  • AT&T is the second largest wireless service provider in North America and one of the world's leading communications service carriers

    80% confidence
  • The wireless industry is currently trading at EV/EBITDA of 9.03X compared with the S&P 500's 17.21X and the sector's 19.40X

    80% confidence
  • Liberty Latin America is poised to benefit from an end-to-end communications platform, leveraging the power of a sub-sea network, fixed-line networks and mobile platforms

    80% confidence
  • Aggressive competition is likely to limit telecom operators' ability to attract and retain customers, affecting operating and financial results

    80% confidence
  • The Zacks Wireless National industry carries a Zacks Industry Rank #166, placing it in the bottom 32% of more than 250 Zacks industries

    80% confidence
  • The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one

    80% confidence
  • The industry is likely to benefit in the long run from a fast-track 5G deployment and extensive fiber densification

    80% confidence
  • Verizon is likely to retain its lead in promulgating 5G mobile networks nationwide by using virtualized machines, advanced levels of operational automation and adaptability

    80% confidence
  • Since 2000, Zacks' top stock-picking strategies have produced average gains of +48.4%, +50.2% and +56.7% per year versus S&P's +7.7% average gain per year

    80% confidence
  • AT&T is benefiting from increased fiber convergence with accelerated growth in fiber customers in areas where it has solid wireless services

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com